Sponsor Information
Sandoz Pty Ltd.
Active Ingredients
Denosumab
418514
WYOST denosumab 70mg/mL (120mg/1.7mL) solution for injection vial
Sandoz Pty Ltd
August 23, 2024
Medicine
Medicine
Registered
Sandoz Pty Ltd.
Denosumab
Empowering clinical research with data-driven insights and AI-powered tools.
© 2025 MedPath, Inc. All rights reserved.